These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3583504)

  • 1. Suppression of basal and Corynebacterium parvum-augmented NK activity during chemically induced tumor development.
    Ghoneum M; Gill G; Wojdani A; Payne C; Alfred LJ
    Int J Immunopharmacol; 1987; 9(1):71-8. PubMed ID: 3583504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive effects of 3-methylcholanthrene on the in vitro antitumor activity of naturally cytotoxic cells.
    Lill PH; Gangemi JD
    J Toxicol Environ Health; 1986; 17(4):347-56. PubMed ID: 3959116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of rat natural killer (NK) cell cytotoxicity and cytokine production by 3-methylcholanthrene (3-MC).
    Talcott PA; Exon JH; Mather GG; Koller LD
    Int J Immunopharmacol; 1990; 12(8):917-26. PubMed ID: 2292469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in natural defense activity against NK-susceptible B16 melanoma cells after treatment with Corynebacterium parvum.
    Karashima A; Taniguchi K; Yoshikai Y; Nomoto K
    Immunobiology; 1991 Aug; 182(5):414-24. PubMed ID: 1916884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and growth of methylcholanthrene-induced tumors in mice with altered immunological status.
    Trutin-Ostović C; Golubić M; Matović M; Marusić M
    Cancer Immunol Immunother; 1986; 23(2):130-6. PubMed ID: 3490910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
    Scott MT; Warner SL
    Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NK cell generation by Corynebacterium parvum.
    Piccoli M; Santoni G; Santoni A; Frati L; Herberman RB; Chirigos MA
    Immunopharmacol Immunotoxicol; 1991; 13(4):513-29. PubMed ID: 1723083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.
    Hassan ZM; Rees RC; Potter CW
    Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii.
    Luft BJ; Remington JS
    J Immunol; 1984 May; 132(5):2375-80. PubMed ID: 6715884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
    Collins AL; Song CW
    Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular suppression of murine ADCC and NK activities induced by Corynebacterium parvum.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Immunol Immunother; 1983; 15(2):149-54. PubMed ID: 6347362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
    Chen MF; Suzuki H; Yano S
    Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice.
    Ojo E; Haller O; Kimura A; Wigzell H
    Int J Cancer; 1978 Apr; 21(4):444-52. PubMed ID: 149772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.